Aaron Wealth Advisors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.27M | Sell |
4,625
-643
| -12% | -$349K | 0.13% | 96 |
|
|
2025
Q4 | $3.05M | Buy |
5,268
+1,062
| +25% | +$601K | 0.17% | 81 |
|
|
2025
Q3 | $2.04M | Buy |
4,206
+2,480
| +144% | +$1.15M | 0.12% | 104 |
|
|
2025
Q2 | $700K | Sell |
1,726
-762
| -31% | -$319K | 0.07% | 176 |
|
|
2025
Q1 | $1.24M | Buy |
2,488
+145
| +6% | +$78.5K | 0.14% | 106 |
|
|
2024
Q4 | $1.22M | Sell |
2,343
-75
| -3% | -$41.2K | 0.14% | 95 |
|
|
2024
Q3 | $1.5M | Buy |
2,418
+535
| +28% | +$317K | 0.18% | 78 |
|
|
2024
Q2 | $1.04M | Buy |
1,883
+216
| +13% | +$124K | 0.14% | 96 |
|
|
2024
Q1 | $969K | Buy |
1,667
+417
| +33% | +$234K | 0.14% | 102 |
|
|
2023
Q4 | $663K | Buy |
1,250
+8
| +0.6% | +$3.87K | 0.11% | 113 |
|
|
2023
Q3 | $629K | Sell |
1,242
-1,863
| -60% | -$993K | 0.08% | 131 |
|
|
2023
Q2 | $1.62M | Sell |
3,105
-56
| -2% | -$30.2K | 0.21% | 72 |
|
|
2023
Q1 | $1.82M | Buy |
3,161
+1,769
| +127% | +$997K | 0.25% | 65 |
|
|
2022
Q4 | $767K | Sell |
1,392
-46
| -3% | -$24.4K | 0.11% | 105 |
|
|
2022
Q3 | $729K | Buy |
1,438
+41
| +3% | +$22.9K | 0.13% | 91 |
|
|
2022
Q2 | $758K | Sell |
1,397
-481,164
| -100% | -$265M | 0.19% | 72 |
|
|
2022
Q1 | $817K | Buy |
482,561
+481,743
| +58,893% | +$277M | 0.01% | 390 |
|
|
2021
Q4 | $545K | Buy |
818
+139
| +20% | +$86.8K | 0.15% | 92 |
|
|
2021
Q3 | $387K | Buy |
679
+16
| +2% | +$8.78K | 0.11% | 107 |
|
|
2021
Q2 | $334K | Hold |
663
| – | – | 0.11% | 117 |
|
|
2021
Q1 | $302K | Sell |
663
-50
| -7% | -$23.9K | 0.11% | 115 |
|
|
2020
Q4 | $332K | Buy |
+713
| New | +$334K | 0.12% | 99 |
|
Other funds holding TMO
VCM
